

Boosting the Economy and Driving Innovation
Between 1998 and 2018, NCI SBIR/STTR awardees fueled $26.1 billion in economic output, 100,000+ jobs, and breakthrough cancer technologies.
Learn MoreLatest Opportunities with SBIR
-
Omnibus Grant Solicitations
The next solicitation deadline is September 5, 2025. Visit the Omnibus Grant Solicitations page for more information on this funding opportunity.
-
Unleash the Potential of Your Cancer Technology with NCI SBIR Support
Learn about the funding and commercialization resources the NCI SBIR Development Center provides to cancer technology innovators across the United States.
-
NCI SBIR x Portal Innovations Webinar
Join NCI SBIR Program Director Sarra Djemil and Director of Investor Relations Brittany Connor as they present an NCI SBIR information session on Wednesday, July 23, 2025.

Success Story: Illumina
Biomedical researchers at Illumina are developing next-generation tools to analyze genetic variation and function on a massive scale. Illumina used NCI SBIR funding to develop their next generation sequencing technology.
Learn More
Why SBIR?